For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
DocGo Inc (NASDAQ: DCGO) closed the day trading at $0.98 down -1.54% from the previous closing price of $1.0. In other words, the price has decreased by -$1.54 from its previous closing price. On the day, 1.15 million shares were traded. DCGO stock price reached its highest trading level at $1.03 during the session, while it also had its lowest trading level at $0.9834.
Ratios:
For a better understanding of DCGO, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1.78. For the most recent quarter (mrq), Quick Ratio is recorded 2.59 and its Current Ratio is at 2.59. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.07.
On February 28, 2025, Deutsche Bank Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $5 to $2.85.
On August 18, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $15.BTIG Research initiated its Buy rating on August 18, 2023, with a $15 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 23 ’25 when Burdiek Michael J bought 10,000 shares for $1.33 per share. The transaction valued at 13,300 led to the insider holds 641,560 shares of the business.
Burdiek Michael J bought 15,000 shares of DCGO for $21,450 on May 15 ’25. The Director now owns 631,560 shares after completing the transaction at $1.43 per share. On May 14 ’25, another insider, Klasko Stephen K. M.D., who serves as the Director of the company, bought 15,000 shares for $1.49 each. As a result, the insider paid 22,350 and bolstered with 15,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DCGO now has a Market Capitalization of 95857112 and an Enterprise Value of 42094860. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.26 while its Price-to-Book (P/B) ratio in mrq is 0.35. Its current Enterprise Value per Revenue stands at 0.114 whereas that against EBITDA is -0.856.
Stock Price History:
The Beta on a monthly basis for DCGO is 0.93, which has changed by -0.76252985 over the last 52 weeks, in comparison to a change of 0.13042927 over the same period for the S&P500. Over the past 52 weeks, DCGO has reached a high of $5.68, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is -11.95%, while the 200-Day Moving Average is calculated to be -42.16%.
Shares Statistics:
Over the past 3-months, DCGO traded about 1.82M shares per day on average, while over the past 10 days, DCGO traded about 463480 shares per day. A total of 97.81M shares are outstanding, with a floating share count of 85.73M. Insiders hold about 12.36% of the company’s shares, while institutions hold 45.92% stake in the company. Shares short for DCGO as of 1764288000 were 4569896 with a Short Ratio of 2.52, compared to 1761868800 on 4395525. Therefore, it implies a Short% of Shares Outstanding of 4569896 and a Short% of Float of 4.760000000000001.
Earnings Estimates
Current recommendations for the stock of the company come from 2.0 analysts. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.2 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$0.42 and -$0.77 for the fiscal current year, implying an average EPS of -$0.6. EPS for the following year is -$0.65, with 2.0 analysts recommending between -$0.56 and -$0.74.
Revenue Estimates
7 analysts predict $70.16M in revenue for. The current quarter. It ranges from a high estimate of $71.3M to a low estimate of $68.98M. As of. The current estimate, DocGo Inc’s year-ago sales were $120.83MFor the next quarter, 7 analysts are estimating revenue of $69.53M. There is a high estimate of $74.5M for the next quarter, whereas the lowest estimate is $64.67M.
A total of 7 analysts have provided revenue estimates for DCGO’s current fiscal year. The highest revenue estimate was $318.56M, while the lowest revenue estimate was $316.24M, resulting in an average revenue estimate of $317.43M. In the same quarter a year ago, actual revenue was $616.56MBased on 7 analysts’ estimates, the company’s revenue will be $290.42M in the next fiscal year. The high estimate is $296.78M and the low estimate is $284.81M.
